Dyne Therapeutics (DYN) Change in Acquisitions & Divestments (2021 - 2026)

Dyne Therapeutics (DYN) has reported Change in Acquisitions & Divestments for 6 consecutive years, with $14.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments rose 168.72% year-over-year to $14.8 million; the TTM figure through Jun 2026 stood at $52.8 million (up 177.47% YoY), while the FY2025 annual figure was $17.9 million, up 69.0% from the prior year.
• Change in Acquisitions & Divestments declined to $14.8 million in Q2 2026 per DYN's latest filing, from $28.6 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $28.6 million in Q1 2026 and bottomed at $1000.0 in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $6.4 million across 5 years, with a median of $2.7 million in 2022.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments tumbled 99.94% — and 2026, when it surged 864.58%.
• Dyne Therapeutics' Change in Acquisitions & Divestments stood at $395000.0 in 2022, then surged by 363.04% to $1.8 million in 2023, then soared by 381.9% to $8.8 million in 2024, then grew by 6.44% to $9.4 million in 2025, then surged by 57.47% to $14.8 million in 2026.
• Business Quant data shows DYN's Change in Acquisitions & Divestments at $14.8 million in Q2 2026, $28.6 million in Q1 2026, and $9.4 million in Q4 2025.